 Patients with Parkinson's disease, for instance, and I'm talking about idiopathic Parkinson's disease, primary, not the secondary Parkinsonism. But primary Parkinson's disease patients do fairly well and respond well to something called carbidopa levodopa because what it is is it's typically a movement disorder that has a lack of dopamine or a neurotransmitter that helps us initiate movements. And that's what you see with President Biden with his slowness of movement, difficulty initiating movements.